Infection control strategy and primary care assistance in Campania region during the national lockdown due to COVID-19 outbreak: the experience of two tertiary emergency centers.
COVID-19
/ epidemiology
Child
Emergency Service, Hospital
/ organization & administration
Female
Hospitals, Pediatric
/ organization & administration
Humans
Infection Control
/ organization & administration
Italy
/ epidemiology
Male
Pandemics
/ prevention & control
Pneumonia, Viral
/ epidemiology
Retrospective Studies
SARS-CoV-2
Time-to-Treatment
Triage
COVID-19
Emergency care
Infection control strategy
Triage
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
29 Jan 2021
29 Jan 2021
Historique:
received:
03
11
2020
accepted:
04
01
2021
entrez:
30
1
2021
pubmed:
31
1
2021
medline:
7
2
2021
Statut:
epublish
Résumé
COVID-19 pandemic has markedly affected emergency care, due to sudden limitation of health care capacity by general practitioners (GP) and urgent need for infection control strategies. We evaluated the activity of the Emergency Department (ED) during the national lockdown (March 8-April 30), as well as the outcomes of our infection control strategy. Despite a reduction in access by one fifth, a proportion of febrile patients comparable to 2019 was seen (829/2492, 33.3% vs 4580/13.342, 34.3%, p = 0.3). Diagnostic swab for COVID-19 was performed in 25% of patients, especially in subjects with co-morbidities or multiple access. Six infected cases were identified, all presenting with febrile disease. Only two positive patients fulfilled the criteria for diagnostic swab provided by the Italian Health Authorities, because of close contact with suspected or confirmed cases. The rate of admission for febrile or respiratory conditions was higher than the same period of 2019 (33.4% vs 25.9%, p < 0.0001). None of the 105 health-care professionals working during the study time lapse exhibited anti-SARS-CoV-2 seroconversion. Among the 589 patients with information available, 54.9% declared no medical consultation at all prior to coming to ED, while only 40 (of which 27 with fever) had been examined by their GP before coming to ED. Nevertheless, 35.6% of the cases were already taking medications. None of the 9 patients requiring intensive care reported recent pediatric consultation, despite symptoms duration up to 30 days. Our results provide evidence that the reduced capacity of primary care facilities during the national lockdown may have caused a high rate of self-medication as well as a delayed provision of care in some patients. Identification of pediatric patients affected with SARS-CoV-2 infection remains a challenge because of the absence of reliable predictive factors. Finally, the use of specific triage centers, with dedicated pathways to diagnose SARS-CoV-2 infection, trace contacts and allow adequate care after swabs, is effective in preventing spreading of the infection.
Sections du résumé
BACKGROUND
BACKGROUND
COVID-19 pandemic has markedly affected emergency care, due to sudden limitation of health care capacity by general practitioners (GP) and urgent need for infection control strategies. We evaluated the activity of the Emergency Department (ED) during the national lockdown (March 8-April 30), as well as the outcomes of our infection control strategy.
RESULTS
RESULTS
Despite a reduction in access by one fifth, a proportion of febrile patients comparable to 2019 was seen (829/2492, 33.3% vs 4580/13.342, 34.3%, p = 0.3). Diagnostic swab for COVID-19 was performed in 25% of patients, especially in subjects with co-morbidities or multiple access. Six infected cases were identified, all presenting with febrile disease. Only two positive patients fulfilled the criteria for diagnostic swab provided by the Italian Health Authorities, because of close contact with suspected or confirmed cases. The rate of admission for febrile or respiratory conditions was higher than the same period of 2019 (33.4% vs 25.9%, p < 0.0001). None of the 105 health-care professionals working during the study time lapse exhibited anti-SARS-CoV-2 seroconversion. Among the 589 patients with information available, 54.9% declared no medical consultation at all prior to coming to ED, while only 40 (of which 27 with fever) had been examined by their GP before coming to ED. Nevertheless, 35.6% of the cases were already taking medications. None of the 9 patients requiring intensive care reported recent pediatric consultation, despite symptoms duration up to 30 days.
CONCLUSION
CONCLUSIONS
Our results provide evidence that the reduced capacity of primary care facilities during the national lockdown may have caused a high rate of self-medication as well as a delayed provision of care in some patients. Identification of pediatric patients affected with SARS-CoV-2 infection remains a challenge because of the absence of reliable predictive factors. Finally, the use of specific triage centers, with dedicated pathways to diagnose SARS-CoV-2 infection, trace contacts and allow adequate care after swabs, is effective in preventing spreading of the infection.
Identifiants
pubmed: 33514406
doi: 10.1186/s13052-021-00963-3
pii: 10.1186/s13052-021-00963-3
pmc: PMC7844775
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
19Références
J Med Virol. 2020 Jul;92(7):747-754
pubmed: 32232980
J Infect. 2020 Apr;80(4):373-377
pubmed: 32109444
Emerg Microbes Infect. 2020 Dec;9(1):1506-1513
pubmed: 32579076
Euro Surveill. 2020 May;25(18):
pubmed: 32400362
J Pediatr. 2020 Jul;222:231-235
pubmed: 32444223
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
Front Pediatr. 2020 Sep 18;8:521
pubmed: 33072657
World J Pediatr. 2020 Jun;16(3):240-246
pubmed: 32026148
Pediatr Emerg Care. 2012 Aug;28(8):753-7
pubmed: 22858740
Acta Clin Belg. 2020 Jun 12;:1-7
pubmed: 32531181
Int J Environ Res Public Health. 2020 Aug 10;17(16):
pubmed: 32785110
Medicina (Kaunas). 2020 May 20;56(5):
pubmed: 32443828
JAMA Pediatr. 2020 Oct 1;174(10):e202430
pubmed: 32492092
Am J Infect Control. 2020 Aug;48(8):933-939
pubmed: 32464297
JAMA Pediatr. 2020 Sep 1;174(9):882-889
pubmed: 32320004
Lancet. 2020 May 2;395(10234):1418-1420
pubmed: 32305073
JAMA Pediatr. 2020 Sep 1;174(9):868-873
pubmed: 32392288
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343